AQEMIA
Dr. Veronique Birault FMedSci serves as the VP of Translational Sciences at AQEMIA, demonstrating a strong leadership role in advancing scientific innovations. Previously, Dr. Birault held the position of Director of Translation at The Francis Crick Institute, where expertise in translating research into practical applications was leveraged. Additionally, Dr. Birault contributed to the field as a Research Fellow at BioFocus, further showcasing a significant dedication to translational research and development in the life sciences.
This person is not in any teams
This person is not in any offices
AQEMIA
4 followers
AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies. Our most advanced programs are currently in vivo optimization. AQEMIA is based in Paris and London.